-
The Ƶ Weekly for December 17th, 2024
The impact of schizophrenia genetic load and heavy cannabis use on the risk of psychotic disorderFull story
Recent and Past Issues
-
Ƶ Weekly for August 8th, 2023
Ƶ Clinical Considerations: Buprenorphine Treatment of Opioid Use DisorderFull story -
Ƶ Weekly for August 1st, 2023
Guest Editorial by David A. Gorelick, MD, PhD, DLFAPA, FƵFull story -
Guest Editorial: The Association of Cannabis Potency with Adverse Psychiatric Effects of Cannabis
Cannabis potency, the content of ∆9-tetrahydrocannabinol (THC), usually expressed as the percentage of dry weight, has increased substantially worldwide over the past four decades [1]. This higher potency poses a risk of increased harms because of evidence of a positive association between cannabis potency and adverse psychiatric effects from long-term cannabis use. This article reviews the evidence for this association.Full story -
Ƶ Weekly for July 25th, 2023
Remove Arbitrary Barrier to Evidence-based Treatment for Stimulant Use DisorderFull story -
Guest Editorial: Remove Arbitrary Barrier to Evidence-based Treatment for Stimulant Use Disorder
Although the current overdose crisis in the US is almost universally referred to as the “opioid” or “fentanyl crisis”1,2, the overdose death rate associated with psychomotor stimulants including methamphetamine and cocaine has also dramatically increased in recent years.Full story -
Ƶ Weekly for July 18th, 2023
Questioning the Right to Pain Relief and Its Role in the Opioid EpidemicFull story -
Ƶ Weekly for July 11th, 2023
Xylazine effects on opioid-induced brain hypoxiaFull story -
Ƶ Weekly for July 4th, 2023
Psychedelics reopen the social reward learning critical periodFull story -
Ƶ Weekly for June 27th, 2023
Reduced Stress-Related Neural Network Activity Mediates the Effect of Alcohol on Cardiovascular RiskFull story -
Ƶ Weekly for June 20th, 2023
Signaling-specific inhibition of the CB1 receptor for cannabis use disorderFull story
This Week in Addiction Medicine Podcast
A weekly audio summary and podcast of the Ƶ Weekly
The Ƶ Weekly
Editors & Staff
Editor-in-Chief: Nicholas Athanasiou, MD, MBA, DFƵ
Emeritus Editor: William Haning, MD, DFAPA, DFƵ
Publications Chair: Nicholas Athanasiou, MD, MBA, DFƵ
Co-Editors: Brandon
Aden, MD, Jack Woodside, MD, John A. Fromson, MD
Please direct customer service inquiries and comments to: ƵWeekly@Ƶ.org
The Ƶ Weekly
Advertiser Services & Sales
Ad space is limited and available on a first-paid, first-published basis. To assure your ad will run in the specific issue you select, Insertion Orders must be signed by an authorized person in your organization and accepted by your customer service representative before taking the advertising units out of the active sales inventory. Payment must be received prior to the run date for an ad. Insertion Orders provide several options for payment in full including all major credit cards or check. Pre-approved billing must be arranged directly by an Ƶ representative.
To learn more about advertising opportunities
Contact: Claire Rasmussen <crasmussen@asam.org>